Morgan Stanley Just Gave a Dire Warning (Most Aren't Ready)
Summary
Felix presents a thesis that the era of a 'one-trick pony' market dominated solely by AI chips and semiconductors is ending. Felix describes a phenomenon called 'the broadening,' where institutional money is rotating out of crowded trades like Nvidia and into the rest of the market. This shift is fueled by three main factors: semiconductor earnings expectations hitting a historical ceiling, falling oil prices reducing inflationary pressure, and a softening Federal Reserve reacting to weak employment data. Felix suggests that the next wave of profits will come from sectors that were previously crushed by high interest rates.
Felix highlights several specific areas for investment during this rotation:
Felix also identifies Biotech, Transports, and Consumer Discretionary as the top three non-tech sectors to watch. Felix specifically highlights Biotech's historical 20% annualized return during rate-cut cycles and the M&A potential as large pharmaceutical companies look to acquire smaller firms to replenish their drug pipelines.
Mentioned Stocks
Reasoning: Felix specifically identifies memory chip companies like Micron as being at the most risk because memory is the most 'commodity-like' part of the semiconductor world, making it prone to wild price swings and crashes.
Reasoning: Felix classifies Meta as a hyperscaler that will benefit from the rotation. Felix notes that Meta selling excess compute capacity signals a peak in chip spending growth, which benefits the buyers of chips over the suppliers.
Reasoning: Felix warns that Nvidia is down 18% from its highs and that the semiconductor trade is 'running out of gas.' Felix believes expectations are at a ceiling and the sector is due for a further correction similar to the recent crash in silver stocks.
Reasoning: Felix recommends Microsoft as a 'hyperscaler' that has already discounted the worst-case scenario after being down nearly 30%. Felix argues that it is a safer bet due to its diversified revenue streams and massive cash generation.
Reasoning: Felix bought Expensify on June 22nd using a systematic process. Felix argues that the stock was a prime candidate for the broadening trade and mentions it has already risen 34% since his purchase.